Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310336517> ?p ?o ?g. }
- W4310336517 endingPage "628" @default.
- W4310336517 startingPage "619" @default.
- W4310336517 abstract "Immune checkpoint inhibitors (ICIs) present significant efficacy in the treatment of malignant tumors, and they have been approved as the first-line of treatment for various cancers. Pembrolizumab monotherapy or combined with chemotherapy has been recommended by domestic and foreign guidelines for the first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma. Although ICIs represent a milestone in the treatment of head and neck squamous cell carcinoma, potential problems still need to be addressed, such as the selection of the efficacy predictors for ICIs, the evaluation of the tumor response to ICIs, and the treatment of immune hyperprogression and immune-related adverse events. Therefore, to form a relatively unified understanding of ICIs treatment for head and neck squamous cell carcinoma, we integrated the clinical experience of multi-disciplinary experts of head and neck cancers on the basis of current clinical hot issues and finally developed this consensus." @default.
- W4310336517 created "2022-12-08" @default.
- W4310336517 creator A5006266198 @default.
- W4310336517 creator A5017649341 @default.
- W4310336517 creator A5020147975 @default.
- W4310336517 creator A5041786187 @default.
- W4310336517 creator A5042241049 @default.
- W4310336517 creator A5044556167 @default.
- W4310336517 creator A5046058427 @default.
- W4310336517 creator A5053088432 @default.
- W4310336517 creator A5058252686 @default.
- W4310336517 creator A5059203169 @default.
- W4310336517 creator A5061005277 @default.
- W4310336517 creator A5064842058 @default.
- W4310336517 creator A5090818171 @default.
- W4310336517 creator A5091230191 @default.
- W4310336517 date "2022-12-01" @default.
- W4310336517 modified "2023-09-24" @default.
- W4310336517 title "The immune checkpoint inhibitors treatment of head and neck squamous cell carcinoma: an expert consensus." @default.
- W4310336517 cites W1940241680 @default.
- W4310336517 cites W1989754098 @default.
- W4310336517 cites W2001973625 @default.
- W4310336517 cites W2010457947 @default.
- W4310336517 cites W2027538916 @default.
- W4310336517 cites W2049553585 @default.
- W4310336517 cites W2062312459 @default.
- W4310336517 cites W2066671159 @default.
- W4310336517 cites W2093334570 @default.
- W4310336517 cites W2100158834 @default.
- W4310336517 cites W2112845420 @default.
- W4310336517 cites W2130808635 @default.
- W4310336517 cites W2272984102 @default.
- W4310336517 cites W2401455386 @default.
- W4310336517 cites W2410569773 @default.
- W4310336517 cites W2523194272 @default.
- W4310336517 cites W2529484692 @default.
- W4310336517 cites W2550291749 @default.
- W4310336517 cites W2554618897 @default.
- W4310336517 cites W2560367415 @default.
- W4310336517 cites W2587048937 @default.
- W4310336517 cites W2592144107 @default.
- W4310336517 cites W2601621622 @default.
- W4310336517 cites W2602907503 @default.
- W4310336517 cites W2605497049 @default.
- W4310336517 cites W2747272999 @default.
- W4310336517 cites W2794739281 @default.
- W4310336517 cites W2799372507 @default.
- W4310336517 cites W2799838772 @default.
- W4310336517 cites W2889646458 @default.
- W4310336517 cites W2891266481 @default.
- W4310336517 cites W2898126801 @default.
- W4310336517 cites W2903493423 @default.
- W4310336517 cites W2986633517 @default.
- W4310336517 cites W3107686376 @default.
- W4310336517 cites W3124559501 @default.
- W4310336517 cites W3126257395 @default.
- W4310336517 cites W3177205810 @default.
- W4310336517 cites W3190270536 @default.
- W4310336517 cites W4200442407 @default.
- W4310336517 doi "https://doi.org/10.7518/hxkq.2022.06.001" @default.
- W4310336517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36416313" @default.
- W4310336517 hasPublicationYear "2022" @default.
- W4310336517 type Work @default.
- W4310336517 citedByCount "1" @default.
- W4310336517 countsByYear W43103365172023 @default.
- W4310336517 crossrefType "journal-article" @default.
- W4310336517 hasAuthorship W4310336517A5006266198 @default.
- W4310336517 hasAuthorship W4310336517A5017649341 @default.
- W4310336517 hasAuthorship W4310336517A5020147975 @default.
- W4310336517 hasAuthorship W4310336517A5041786187 @default.
- W4310336517 hasAuthorship W4310336517A5042241049 @default.
- W4310336517 hasAuthorship W4310336517A5044556167 @default.
- W4310336517 hasAuthorship W4310336517A5046058427 @default.
- W4310336517 hasAuthorship W4310336517A5053088432 @default.
- W4310336517 hasAuthorship W4310336517A5058252686 @default.
- W4310336517 hasAuthorship W4310336517A5059203169 @default.
- W4310336517 hasAuthorship W4310336517A5061005277 @default.
- W4310336517 hasAuthorship W4310336517A5064842058 @default.
- W4310336517 hasAuthorship W4310336517A5090818171 @default.
- W4310336517 hasAuthorship W4310336517A5091230191 @default.
- W4310336517 hasConcept C121608353 @default.
- W4310336517 hasConcept C126322002 @default.
- W4310336517 hasConcept C141071460 @default.
- W4310336517 hasConcept C143998085 @default.
- W4310336517 hasConcept C197934379 @default.
- W4310336517 hasConcept C2776530083 @default.
- W4310336517 hasConcept C2776694085 @default.
- W4310336517 hasConcept C2776833033 @default.
- W4310336517 hasConcept C2777701055 @default.
- W4310336517 hasConcept C2780057760 @default.
- W4310336517 hasConcept C3018411727 @default.
- W4310336517 hasConcept C71924100 @default.
- W4310336517 hasConceptScore W4310336517C121608353 @default.
- W4310336517 hasConceptScore W4310336517C126322002 @default.
- W4310336517 hasConceptScore W4310336517C141071460 @default.
- W4310336517 hasConceptScore W4310336517C143998085 @default.
- W4310336517 hasConceptScore W4310336517C197934379 @default.
- W4310336517 hasConceptScore W4310336517C2776530083 @default.